{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:40:27Z","timestamp":1771958427796,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The melatonin receptor (MT) agonist ramelteon has a higher affinity to MT1 than for MT2 receptors and induces cardioprotection by involvement of mitochondrial potassium channels. Activation of mitochondrial potassium channels leads to release of free radicals. We investigated whether (1) ramelteon-induced cardioprotection is MT2 receptor specific and (2) if free radicals are involved in ramelteon-induced cardioprotection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Hearts of male Wistar rats were randomized, placed on a Langendorff system, and perfused with Krebs-Henseleit buffer at a constant pressure of 80\u00a0mmHg. All hearts were subjected to 33\u00a0min of global ischemia and 60\u00a0min of reperfusion. Before ischemia hearts were perfused with ramelteon (Ram) with or without the MT2 receptor inhibitor 4-phenyl-2-propionamidotetralin (4P-PDOT+Ram, 4P-PDOT). In subsequent experiments, ramelteon was administered together with the radical oxygen species (ROS) scavenger N-2-mercaptopropionylglycine (MPG+Ram). To determine whether the blockade of ramelteon-induced cardioprotection can be restored, we combined ramelteon and MPG with mitochondrial permeability transition pore (mPTP) inhibitor cyclosporine A (CsA) at different time points. Infarct size was determined by triphenyltetrazolium chloride (TTC) staining.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ramelteon-induced infarct size reduction was completely blocked by 4P-PDOT and MPG. Ramelteon and MPG combined with CsA before ischemia were not cardioprotective but CsA at the onset of reperfusion could restore infarct size reduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study shows for the first time that despite the higher affinity to MT1 receptors, (1) ramelteon-induced cardioprotection involves MT2 receptors, (2) cardioprotection requires ROS release, and (3) inhibition of the mPTP can restore infarct size reduction.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10557-020-06972-4","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T10:03:28Z","timestamp":1585649008000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species"],"prefix":"10.1007","volume":"34","author":[{"given":"Martin","family":"Stroethoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Torregroza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bunte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Raupach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Heinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Mathes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnar","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"issue":"8","key":"6972_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/01.CIR.97.8.795","volume":"97","author":"K Matsumura","year":"1998","unstructured":"Matsumura K, Jeremy RW, Schaper J, Becker LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation. 1998;97(8):795\u2013804.","journal-title":"Circulation."},{"issue":"5","key":"6972_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124\u201336.","journal-title":"Circulation."},{"issue":"5","key":"6972_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1213\/01.ANE.0000181336.96511.32","volume":"101","author":"D Obal","year":"2005","unstructured":"Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005;101(5):1252\u201360.","journal-title":"Anesth Analg"},{"issue":"8","key":"6972_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12630-010-9325-1","volume":"57","author":"J Frassdorf","year":"2010","unstructured":"Frassdorf J, Huhn R, Niersmann C, Weber NC, Schlack W, Preckel B, et al. Morphine induces preconditioning via activation of mitochondrial K(Ca) channels. Can J Anaesth. 2010;57(8):767\u201373.","journal-title":"Can J Anaesth"},{"issue":"5","key":"6972_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/ALN.0b013e3181895aa0","volume":"109","author":"A Heinen","year":"2008","unstructured":"Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, et al. Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+)-sensitive potassium channel activation. Anesthesiology. 2008;109(5):830\u20136.","journal-title":"Anesthesiology."},{"issue":"2","key":"6972_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/FJC.0000000000000600","volume":"72","author":"M Stroethoff","year":"2018","unstructured":"Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, et al. Melatonin receptor agonist ramelteon reduces ischemia-reperfusion injury through activation of mitochondrial potassium channels. J Cardiovasc Pharmacol. 2018;72(2):106\u201311.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"6972_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuropharm.2004.09.007","volume":"48","author":"K Kato","year":"2005","unstructured":"Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1\/MT2 receptor agonist. Neuropharmacology. 2005;48(2):301\u201310.","journal-title":"Neuropharmacology."},{"issue":"1","key":"6972_CR8","doi-asserted-by":"publisher","first-page":"C148","DOI":"10.1152\/ajpcell.00215.2006","volume":"292","author":"A Heinen","year":"2007","unstructured":"Heinen A, Camara AK, Aldakkak M, Rhodes SS, Riess ML, Stowe DF. Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol. 2007;292(1):C148\u201356.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"6972_CR9","doi-asserted-by":"publisher","first-page":"e0144737","DOI":"10.1371\/journal.pone.0144737","volume":"10","author":"F Behmenburg","year":"2015","unstructured":"Behmenburg F, Dorsch M, Huhn R, Mally D, Heinen A, Hollmann MW, et al. Impact of mitochondrial Ca2+-sensitive potassium (mBKCa) channels in sildenafil-induced cardioprotection in rats. PLoS One. 2015;10(12):e0144737.","journal-title":"PLoS One"},{"key":"6972_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.exger.2014.03.029","volume":"56","author":"A Heinen","year":"2014","unstructured":"Heinen A, Strothoff M, Schmidt A, Stracke N, Behmenburg F, Bauer I, et al. Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BK(Ca) signaling pathway. Exp Gerontol. 2014;56:99\u2013105.","journal-title":"Exp Gerontol"},{"issue":"12","key":"6972_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/intimm\/dxv035","volume":"27","author":"V Cernysiov","year":"2015","unstructured":"Cernysiov V, Mauricas M, Girkontaite I. Melatonin inhibits granulocyte adhesion to ICAM via MT3\/QR2 and MT2 receptors. Int Immunol. 2015;27(12):599\u2013608.","journal-title":"Int Immunol"},{"issue":"7","key":"6972_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1071\/RD14302","volume":"28","author":"M Gonzalez-Arto","year":"2016","unstructured":"Gonzalez-Arto M, Luna C, Perez-Pe R, Muino-Blanco T, Cebrian-Perez JA, Casao A. New evidence of melatonin receptor contribution to ram sperm functionality. Reprod Fertil Dev. 2016;28(7):924\u201335.","journal-title":"Reprod Fertil Dev"},{"issue":"4","key":"6972_CR13","doi-asserted-by":"publisher","first-page":"E507","DOI":"10.3390\/jcm8040507","volume":"8","author":"A Raupach","year":"2019","unstructured":"Raupach A, Reinle J, Stroethoff M, Mathes A, Heinen A, Hollmann MW, et al. Milrinone-induced pharmacological preconditioning in cardioprotection: hints for a role of mitochondrial mechanisms. J Clin Med. 2019;8(4):E507.","journal-title":"J Clin Med"},{"issue":"3","key":"6972_CR14","doi-asserted-by":"publisher","first-page":"e0151025","DOI":"10.1371\/journal.pone.0151025","volume":"11","author":"M Dorsch","year":"2016","unstructured":"Dorsch M, Behmenburg F, Raible M, Blase D, Grievink H, Hollmann MW, et al. Morphine-induced preconditioning: involvement of protein kinase A and mitochondrial permeability transition pore. PLoS One. 2016;11(3):e0151025.","journal-title":"PLoS One"},{"key":"6972_CR15","unstructured":"Canadian Institutes of Health Research, Alberta Innovates - Health Solutions; The Metabolomics Innovation Centre (TMIC). Drugbank [database on the Internet] 2019."},{"issue":"4","key":"6972_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1034\/j.1600-079X.2002.02924.x","volume":"33","author":"E Sahna","year":"2002","unstructured":"Sahna E, Acet A, Ozer MK, Olmez E. Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res. 2002;33(4):234\u20138.","journal-title":"J Pineal Res"},{"issue":"2","key":"6972_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1124\/jpet.104.074476","volume":"312","author":"CM Cao","year":"2005","unstructured":"Cao CM, Xia Q, Gao Q, Chen M, Wong TM. Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning. J Pharmacol Exp Ther. 2005;312(2):644\u201350.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"6972_CR18","doi-asserted-by":"publisher","first-page":"H434","DOI":"10.1152\/ajpheart.00763.2005","volume":"290","author":"DF Stowe","year":"2006","unstructured":"Stowe DF, Aldakkak M, Camara AK, Riess ML, Heinen A, Varadarajan SG, et al. Cardiac mitochondrial preconditioning by Big Ca2+-sensitive K+ channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol. 2006;290(1):H434\u201340.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"6972_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.exger.2011.11.003","volume":"47","author":"R Huhn","year":"2012","unstructured":"Huhn R, Weber NC, Preckel B, Schlack W, Bauer I, Hollmann MW, et al. Age-related loss of cardiac preconditioning: impact of protein kinase A. Exp Gerontol. 2012;47(1):116\u201321.","journal-title":"Exp Gerontol"},{"issue":"Pt 14","key":"6972_CR20","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1113\/jphysiol.2010.187641","volume":"588","author":"WJ Zhao","year":"2010","unstructured":"Zhao WJ, Zhang M, Miao Y, Yang XL, Wang Z. Melatonin potentiates glycine currents through a PLC\/PKC signalling pathway in rat retinal ganglion cells. J Physiol. 2010;588(Pt 14):2605\u201319.","journal-title":"J Physiol"},{"issue":"3","key":"6972_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-079X.2008.00593.x","volume":"45","author":"I Stumpf","year":"2008","unstructured":"Stumpf I, Muhlbauer E, Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res. 2008;45(3):318\u201327.","journal-title":"J Pineal Res"},{"issue":"4","key":"6972_CR22","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, et al. Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018;314(4):H812\u2013H38. https:\/\/doi.org\/10.1152\/ajpheart.00335.2017.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"5","key":"6972_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359(5):473\u201381.","journal-title":"N Engl J Med"},{"issue":"12","key":"6972_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jacc.2009.10.052","volume":"55","author":"N Mewton","year":"2010","unstructured":"Mewton N, Croisille P, Gahide G, Rioufol G, Bonnefoy E, Sanchez I, et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol. 2010;55(12):1200\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"6972_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021\u201331.","journal-title":"N Engl J Med"},{"issue":"4","key":"6972_CR26","doi-asserted-by":"publisher","first-page":"H1218","DOI":"10.1152\/ajpheart.2000.278.4.H1218","volume":"278","author":"JR Kersten","year":"2000","unstructured":"Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol. 2000;278(4):H1218\u201324.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"6972_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bpa.2007.08.003","volume":"22","author":"YH Shim","year":"2008","unstructured":"Shim YH, Kersten JR. Preconditioning, anesthetics, and perioperative medication. Best Pract Res Clin Anaesthesiol. 2008;22(1):151\u201365.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"6972_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/bja\/aen022","volume":"100","author":"R Huhn","year":"2008","unstructured":"Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008;100(4):465\u201371.","journal-title":"Br J Anaesth"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06972-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-020-06972-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06972-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:36:13Z","timestamp":1666229773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-020-06972-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["6972"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-06972-4","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"31 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}